SOTAC PHARMACEUTICALS
Back to Income Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹104 Cr | ₹77 Cr | ₹73 Cr | ₹49 Cr | ₹29 Cr |
What is the latest Revenue of SOTAC PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹77 Cr |
| Mar2023 | ₹73 Cr |
| Mar2022 | ₹49 Cr |
| Mar2021 | ₹29 Cr |
How is Revenue of SOTAC PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 34.00 | |
| Mar2024 | ₹77 Cr | 5.92 | |
| Mar2023 | ₹73 Cr | 49.77 | |
| Mar2022 | ₹49 Cr | 70.76 | |
| Mar2021 | ₹29 Cr | - | |
Compare Revenue of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹110.6 Cr | -4.3% | -0.7% | -12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -4.3% |
-0.7% |
-12.2% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses